Critical steps in the protocol
The most critical step in the finite element model-based updating approach lies in the iterative procedure. In the approach, the finite element model should accurately recover the coronary vessel motion on the vascular cross-section from in vivo cine IVUS images. To this purpose, minimizing the lumen circumference difference between the finite element model and in vivo images was adopted in this study to find the proper material properties. There were other key steps in the protocols, including image segmentation and processing, finite element model construction, and iterative schemes to quantify coronary vessel material properties. An improvement was to implement the automatic delineation of coronary plaque components to save time.
Significance of finite element modeling-based updating approach
Classically, mechanical experiments such as uniaxial/biaxial tensile testing, indentation testing, and pressure inflation testing were conducted to quantify the mechanical behavior of the cardiovascular tissues ex vivo8,16. The clinical application of these approaches was limited due to the following reasons: 1) Ex vivo coronary arterial tissue samples are often not available. It is almost impossible to harvest the normal coronary samples in the clinical setting; 2) Material properties of arterial tissues might alter when taken out of living subjects; 3) it is not suitable for continuous monitoring in a patient-specific setting for personal management and precision medicine. Fortunately, FEMBUA provides another way to determine patient-specific tissue properties in vivo. The in vivo method could be easily modified to successfully apply to other biological tissues, such as aortic tissues19 and cardiac tissue20, and even non-biological materials like metal21. Prior studies have demonstrated that patient-specific in vivo tissue material properties had a significant influence on cardiovascular biomechanics, especially in strain calculation, compared to ex vivo material properties11. Therefore, patient-specific in vivo material properties are desirable for personalized treatment.
Even though in vivo and ex vivo methods are different, they could be integrated to inspire other approaches to quantify the mechanical properties of cardiovascular tissues. A hybrid approach that combines FEMBUA to match stress-strain data from biaxial/uniaxial experiments has been proposed for the aortic aneurysmal tissue22.
Potential clinical applications of Finite Element Modeling Based Updating Approach
FEMBUA based on IVUS image is of great importance in cardiovascular materials science, medical image analysis, and personalized medical device design. This proposed method does not need to cause dramatic damage to the investigated coronary vessel wall as in a situation like taking the tissue out of the living human body, so it is suitable for continuous patient monitoring, such as investigating the effect of in vivo mechanical properties on patient prognosis, which cannot be done by a classical mechanical experimental approach. In addition, the proposed FEMBUA method plays a key role in the treatment optimization of coronary stents and the diagnosis of cardiovascular diseases. Finely analyzing the structure and lesion characteristics of blood vessel walls could guide the selection of stent size and location, thus maintaining the structural and mechanical stability within tissues to a higher degree, reducing complications, and improving patient prognosis23. In summary, the FEMBUA method has extensive and far-reaching application potential in the cardiovascular field.
Comparison of results from FEMBUA and ex vivo experimental approaches
Comparison analysis between FEMBUA and classical ex vivo experimental approaches has been conducted to assess the accuracy and efficacy of the novel in vivo approach. For simplification, coronary tissue stiffness from the mechanical approach was compared to those from in vivo studies using FEMBUA, and tissue stiffness from both methods was generally in the same magnitude range11. The consistency was also confirmed in other vascular beds like aorta and carotid artery24. Of note that the limited number of ex vivo studies could influence the conclusions abovementioned, since the tissue stiffness variability across different individuals is also pronounced. Nevertheless, these conclusions suggested that FEMBUA is an accurate and effective approach to quantifying the material properties of arterial walls.
Validation and robustness of FEMBUA method were also investigated by performing both the in vivo FEMBUA method and ex vivo experiment on the same arterial tissue for validation purposes25,26,27. Liu et al. conducted in vivo and ex vivo experimental approaches on aortic tissues. Their findings revealed a close correlation between the material behavior curves generated by both methods, with an average mean absolute percentage error smaller than 5%25. Further, Cosentino et al. performed a similar comparative analysis based on a larger sample cohort (n=10), with similar conclusions obtained27. These findings collectively showed that FEMBUA could yield minimal discrepancies in biomechanical outcomes for identical samples. A further study also showed that the proposed method is reproducible and robust, as the study demonstrated that variations in mechanical properties had minimal impact on the simulated biomechanical outcomes in coronary artery models through finite element analysis27.
Modeling assumptions and limitations
There are some assumptions involved in FEM for in vivo identification of the material properties of coronary arterial walls, which would impact the results from FEMBUA as described here. The axial shrinkage rate was assumed to be 95% since the actual axial shrinkage could not be obtained under in vivo conditions. The impact of axial stretch on material properties was investigated in prior studies, and the results indicated that smaller axial stretch led to greater slice shrinkage and softer material stiffness estimation11,28,29,30. Therefore, patient-specific axial stretch data should be used when available. The quality evaluation of finite element mesh involves several key indicators, among which the shape of the mesh element is the main evaluation criterion in this paper, which is directly related to the stability of the numerical solution and iterative convergence. In practical applications, due to the complexity of the problem, it is necessary to weigh the indicators to meet the analysis needs, and if necessary, the mesh quality can be optimized by designing new segmentation methods and selecting suitable mesh types31. Special attention should be paid to small lipids at key sites during actual segmentation32,33,34. In this implementation, small lipids in key sites (fibrous cap and shoulder) are retained, while lipids in other sites which have little influence on the stress/strain conditions. Blood pressure measured by arm cuff was used as a surrogate for on-site intracoronary pressure since invasive intracoronary pressure was not available for the patient. Active stress in the coronary artery was not considered since early evidence suggested that its contribution to the elastic properties of the living blood vessel was very small35. Residual stress information was not available and thus was not included in this model36,37. Structure-only models rather than more complex fluid-structure interaction models were used in the FEMBUA method, given it is more computationally efficient as iterative procedures typically need to solve the computational models several times to find the material properties constant.
In summary, image-based FEMBUA, different from other classical ex vivo experimental approaches, could be used to effectively determine the patient-specific material properties of coronary vessels in vivo. Since arterial tissue stiffness has already been employed in clinical settings as a risk factor for cardiovascular diseases, FEMBUA makes it possible to continuously monitor the coronary arterial mechanical properties under in vivo conditions and thus holds the potential in clinical applications for personalized treatment and precision medicine.